Technical guide covering pharmaceutical gelatin sources, Type A and B processing, gelling and film behavior, Bloom and viscosity considerations, dosage-form use, traceability, and pharmacopeial controls.
Pharma grade gelatin is a purified protein obtained through partial hydrolysis of collagen, the structural protein found in animal connective tissue. Its molecular backbone consists mainly of amino acid sequences rich in glycine, proline, and hydroxyproline, with smaller amounts of alanine, glutamic acid, arginine, and other residues. These repeating sequences give gelatin its characteristic triple-helix-derived chain structure, which after processing allows the material to form thermoreversible gels and coherent films.
In pharmaceutical production, bovine raw materials are commonly divided into hide-based and bone-based sources. Bovine hide gelatin is generally produced from skin splits and hide trimmings, while bone gelatin is derived from ossein, the collagen-bearing fraction of demineralized cattle bones. The raw material source influences pretreatment design and contributes to differences in processing behavior, but source alone does not determine pharmaceutical suitability. Controlled conditioning, extraction, and purification are equally important.
Gelatin type is defined by two principal processing routes. Type A gelatin is produced through acid conditioning and typically reflects the chemistry of acid-processed collagen. Type B gelatin is produced through alkaline or lime conditioning, a route historically associated with bovine bone and certain hide materials. The conditioning route affects isoionic behavior and functional characteristics, enabling formulators to select a gelatin type suited to specific dosage-form requirements.
| Dimension | Hide-derived route | Bone-derived route |
|---|---|---|
| Collagen-bearing material | Bovine skin splits and hide trimmings | Ossein released from demineralized cattle bone |
| Common conditioning | Frequently associated with acid processing for Type A gelatin, subject to material and grade design | Frequently associated with alkaline or lime processing for Type B gelatin, subject to material and grade design |
| Primary control focus | Source traceability, pretreatment, extraction, and purification control | Demineralization, source traceability, extended conditioning, extraction, and purification control |
| Formulation relevance | Functional profile is established by the full process, not by hide origin alone | Functional profile is established by the full process, not by bone origin alone |
Source control is central to pharmaceutical use because gelatin is an animal-derived ingredient. Traceability systems connect finished batches to raw material origin, supplier documentation, and processing records. For bovine materials, manufacturers commonly apply BSE/TSE risk-material control concepts, including sourcing controls, segregation of specified risk materials where applicable, and documentation supporting animal origin. Traceability does not replace pharmacopeial testing, but it provides the chain-of-custody foundation needed to investigate batches, support quality review, and demonstrate that raw material inputs were managed under pharmaceutical-grade controls.
Pharma grade gelatin differs from food or industrial grades not because of any single property, but because of a controlled combination of functional performance, purity, microbiological quality, and documentation. Its principal functional properties include gelling capacity, thermoreversible sol–gel transition, film formation, water binding, emulsification support, and solubility under suitable temperature and hydration conditions. These properties determine how the material behaves during capsule molding, gel setting, granulation, coating, and fill encapsulation.
Gelling and film-forming behavior are particularly important in dosage-form manufacturing. A gelatin solution must hydrate uniformly, be processed at a controlled temperature, set within an appropriate time, and form a shell or film with adequate strength and flexibility. Water-binding capacity affects drying behavior and interaction with aqueous formulations, while solubility influences dissolution and the preparation of processing solutions. Clarity, color, and odor are also monitored because visible haze, abnormal color, or off-odor may point to raw material variation, inadequate processing, or degradation.
Pharmaceutical specifications commonly cover identity, pH, gel strength, viscosity, moisture, ash, sulfur dioxide, heavy metals, peroxide or oxidation-related residues, particulate and insoluble matter, and microbial limits. Exact acceptance criteria depend on the applicable pharmacopeial monograph, grade designation, and dosage-form requirement. Unlike lower-grade gelatins, pharmaceutical-grade material is expected to be manufactured under appropriate controls and released against documented batch parameters.
| Specification category | Representative items | Formulation or quality relevance |
|---|---|---|
| Identity and description | Material identity, source/type description, appearance | Confirms that the tested material matches the intended excipient and purchasing specification |
| Functional properties | Gel strength, viscosity, gelling behavior, film-forming behavior | Supports capsule forming, setting, granulation, coating, and processing-window design |
| Physical properties | pH, moisture, clarity, color, odor, insoluble matter | Affects compatibility, visual quality, hydration, drying, and handling |
| Chemical purity | Ash, sulfur dioxide, heavy metals, peroxide or oxidation-related residues | Helps control chemical interference, residue exposure, and stability risks |
| Microbiological quality | Microbial limits and specified objectionable organisms required by the applicable specification | Supports excipient safety and control of downstream bioburden risk |
| Batch documentation | Batch number, tested parameters, traceability records, certificate of analysis | Links release results to production history and animal-origin records |
For formulation performance, the most important properties are those that directly affect processing and finished-product behavior. Bloom strength and viscosity govern solution and gel mechanics; pH supports compatibility with actives and other excipients; low residue and ash levels help reduce chemical interference; and microbial limits support product safety. Specifications should therefore be interpreted as an integrated package rather than as isolated pass/fail values. A gelatin may meet a gel-strength target and still be unsuitable if purity, odor, microbial quality, or traceability documentation is inadequate.
Bloom gel strength is the standard measure of the force required to depress the surface of a standardized gelatin gel under defined preparation and test conditions. In the Bloom test, a gelatin solution of specified concentration is prepared, matured at a controlled temperature for a set time, and measured with a texture analyzer fitted with a standard probe. The result, expressed in Bloom grams, describes gel firmness under those conditions; it is not a complete measure of overall formulation performance.
Viscosity describes the flow resistance of a gelatin solution under defined concentration and temperature conditions. It affects dipping and spreading during capsule manufacture, pump transfer, bubble release, coating uniformity, and setting behavior. Gel strength and viscosity are related but not interchangeable. A high-Bloom gelatin may produce a firm gel, while solution viscosity independently affects film thickness, machine runnability, and drying. Formulation teams should evaluate both parameters together.
| Parameter | What it measures | Standardized test basis | Main process implication |
|---|---|---|---|
| Bloom strength | Resistance of a matured gelatin gel to probe penetration | Defined gel concentration, maturation temperature, maturation time, and probe method | Gel firmness, shell rigidity, setting structure, and network strength |
| Viscosity | Flow resistance of a gelatin solution | Defined solution concentration and measurement temperature | Film thickness, dipping or spreading behavior, transfer, bubble release, and drying |
| Molecular weight distribution | Relative chain-length population generated by hydrolysis and extraction | Not a single Bloom or viscosity value; assessed through the material's analytical profile where required | Influences both network formation and solution flow, so it should be interpreted with both functional parameters |
Molecular weight distribution underlies both properties. Extraction and hydrolysis generate chains of varying length. Longer, less fragmented chains generally support stronger network formation, while chain distribution affects viscosity and setting behavior. During cooling, gelatin chains reorganize into junction zones that immobilize water and create the gel. Concentration, temperature, cooling rate, setting time, and interactions with other ingredients all modify the final gel network.
Application-oriented Bloom and viscosity choices should reflect dosage-form needs rather than universal rules. Hard capsule production commonly requires gelatins capable of forming strong, uniform films with controlled setting. Softgels additionally require compatibility with plasticizers and fill systems. Tablet binding and granulation applications may prioritize solution viscosity, adhesion, and compactability over the highest Bloom value. Because no verified numeric ranges or supplier COA dataset are provided here, application-specific Bloom and viscosity targets should be selected through formulation trials and process validation using the applicable supplier specification and pharmacopeial method. Treating Bloom as the only criterion can lead to poor machine performance, shell defects, or incompatibility with active ingredients and plasticizers.
Pharma grade gelatin is used across multiple dosage forms because it combines gelling, film-forming, binding, and dissolution properties. Its largest pharmaceutical applications are hard capsules and softgels, but it is also used in tablet granulation, film coatings, microencapsulation, and specialized formulations requiring controlled film formation or gel structure.
| Dosage form or process | Primary gelatin function | Key compatibility or processing considerations |
|---|---|---|
| Hard capsules | Forms a rigid, uniform shell from a controlled aqueous gelatin film | Bloom strength, viscosity, setting behavior, clarity, shell moisture, drying, and dissolution performance |
| Softgels | Forms a flexible shell when combined with plasticizer and water | Compatibility with glycerol, sorbitol, other plasticizers, active ingredients, and oily or non-aqueous fills; water migration and cross-linking potential |
| Tablets and wet granulation | Binds particles and supports granule cohesion and compact strength | Solution viscosity, adhesion, hydration, drying, granule behavior, and compatibility with active ingredients |
| Film coatings | Supports continuous film formation on dosage-unit surfaces | Solution preparation, coating uniformity, drying conditions, and interaction with other coating components |
| Microencapsulation | Acts as a film-forming wall material for particle separation or functional concepts | Core material compatibility, water sensitivity, pH effects, and intended release behavior |
In hard capsule manufacturing, gelatin solutions are prepared with water and formed into shells on precision molds. The gelatin must provide sufficient Bloom strength for a rigid shell, controlled viscosity for uniform film thickness, appropriate setting behavior for machine speed, and clarity consistent with visual quality requirements. Dried shells must remain mechanically robust while still dissolving after administration. Shell moisture is carefully controlled because excessive brittleness or flexibility can affect filling, closure, and storage performance.
In softgels, gelatin is combined with plasticizers such as glycerol or sorbitol to produce a flexible shell. The gelatin–plasticizer–water system must be compatible with the fill material, which may be oily, non-aqueous, or otherwise formulated to prevent undesirable shell interaction. Formulators assess water migration, cross-linking potential, pH effects, and chemical compatibility among active ingredients, excipients, and shell components.
In tablets, gelatin can serve as a binder in wet granulation, contributing cohesion between particles and supporting compact strength. It may also be used in coating systems or as a wall material in microencapsulation, where film formation can support particle separation, taste masking, or controlled-release concepts. Its compatibility with water, glycerol, sorbitol, active ingredients, and fill materials must be evaluated case by case.
Application constraints include hydration temperature, solution concentration, drying conditions, microbial control during intermediate holding, and interactions with reactive or highly ionic actives. Selection should therefore follow dosage-form function and process conditions rather than assuming that one gelatin type is universally suitable for capsules, tablets, and coatings.
Pharmaceutical bovine gelatin is manufactured through a sequence of raw material preparation, conditioning, controlled hydrolysis, extraction, purification, concentration, drying, and milling. The process converts insoluble collagen into soluble gelatin while managing chain length, purity, odor, color, microbial load, and batch-to-batch consistency. The main distinction between Type A and Type B gelatin comes from acid or alkaline conditioning before hot-water extraction.
| Process stage | Controlled variables | Potential effect on finished gelatin |
|---|---|---|
| Raw material pretreatment | Hide or bone source, cleaning, size reduction, removal of non-collagenous material, bone demineralization where applicable | Affects collagen accessibility, impurity load, and the achievable balance of gel strength and viscosity |
| Acid conditioning for Type A | Acidic chemical environment, treatment time, temperature, and neutralization before extraction | Produces acid-processed gelatin characteristics and modifies chain behavior according to raw material and controls |
| Alkaline conditioning for Type B | Alkaline or lime environment, extended holding time, temperature, washing, and neutralization | Produces alkaline-processed gelatin characteristics and modifies purity, chemistry, and functional behavior |
| Multi-stage hot-water extraction | Temperature, pH, extraction time, water ratio, concentration, and extraction fraction | Controls hydrolysis, molecular weight distribution, Bloom strength, viscosity, yield, color, and odor |
| Downstream finishing | Filtration, ion exchange or demineralization, evaporation, sterilization, drying, and milling | Refines purity, microbiological quality, moisture, particle size, and consistency |
Raw material selection begins with source approval and traceability. Bovine hide or bone material is cleaned, size-reduced, and pretreated to remove non-collagenous material. Bone material may undergo demineralization to release ossein, while hide material is prepared through washing and chemical conditioning appropriate to its composition. These pretreatment steps affect collagen accessibility and the subsequent balance between gel strength and viscosity.
In the acid process, collagen is conditioned under acidic conditions and then extracted with controlled hot water. In the alkaline process, the material is held under alkaline or lime conditions for an extended period before neutralization and extraction. Each route changes the chemical environment and chain behavior of the resulting gelatin, contributing to Type A or Type B characteristics. Process selection depends on the raw material, target functional profile, and intended pharmaceutical application.
Multi-stage hot-water extraction is a key quality-control operation. Earlier extraction fractions generally retain longer molecular chains and stronger gelling potential, while later fractions may show lower gel strength and different viscosity. Temperature, pH, extraction time, water ratio, and concentration are controlled to avoid excessive hydrolysis while achieving adequate yield. Deviations can shift molecular weight distribution, weaken Bloom strength, alter viscosity, or increase color and odor.
After extraction, the gelatin liquor is filtered to remove insoluble matter, treated by ion exchange or demineralization where appropriate, concentrated by evaporation, sterilized under controlled thermal conditions, dried, and milled to a specified particle size. These downstream steps refine purity and microbiological quality, but the functional grade is largely established earlier through raw material, conditioning, and extraction parameters. Consistent control of these variables is what connects process control to reproducible capsule, tablet, and coating performance.
Purification and microbiological control are essential because pharma grade gelatin is derived from natural raw materials and passes through aqueous stages where microbial growth or chemical carryover can occur if controls are inadequate. Downstream treatment combines physical separation, chemical refinement, concentration, thermal treatment, drying, and batch testing to reduce particulate, ionic, microbial, and residue-related risks.
Filtration removes insoluble particles and residual tissue debris, while ion exchange and demineralization reduce ionic impurities and can improve ash, conductivity-related quality, clarity, and chemical stability. Evaporation concentrates the gelatin liquor under controlled thermal conditions. Sterilization may use UHT or an equivalent validated heat-treatment concept designed to reduce vegetative microbial load before drying and packaging. These steps support low bioburden, but they do not make the finished ingredient sterile unless a separate sterile manufacturing and packaging system is established and demonstrated.
| Control or test area | Typical items | Purpose in batch disposition |
|---|---|---|
| Purification controls | Filtration, ion exchange, demineralization, evaporation, and controlled thermal treatment | Reduce particulate, ionic, chemical, and vegetative microbial load before drying and packaging |
| Microbiological tests | Bioburden, total aerobic microbial count, Salmonella, Escherichia coli, and other organisms required by the applicable monograph or specification | Demonstrate conformity with defined microbial-limit requirements; they do not establish sterility |
| Chemical and physical tests | Heavy metals, ash, sulfur dioxide, peroxide or oxidation indicators, pH, moisture, insoluble matter, Bloom strength, and viscosity | Assess purity, residue control, stability indicators, and functional performance |
| Documentation and traceability | Batch records, processing records, test results, COA, packaging integrity, and raw-material linkage | Support release review, investigation, and traceability from finished lot to source material |
Microbiological release testing commonly includes bioburden assessment, total aerobic microbial count, and tests for specified objectionable organisms relevant to pharmaceutical excipients, such as Salmonella and Escherichia coli, together with other organisms required by the applicable monograph or specification. Chemical and physical testing may cover heavy metals, ash, sulfur dioxide, peroxide or oxidation indicators, pH, moisture, insoluble matter, Bloom strength, and viscosity. The exact test set and limits are defined by pharmacopeial requirements, customer specifications, and intended use.
Critical quality-control points include incoming raw material review, in-process monitoring of extraction and purification, filtration integrity, thermal treatment records, concentration and drying controls, packaging integrity, and final batch disposition. A certificate of analysis typically records tested batch parameters and supports traceability from the finished lot back to production records and raw material source.
Microbial quality control must not be confused with a sterility claim. Pharma grade gelatin can meet pharmacopeial microbial limits without being sterile. Dosage-form manufacturers remain responsible for controlling subsequent hydration, holding, compounding, and any terminal sterilization requirements applicable to the finished pharmaceutical product.
Pharma grade gelatin should be stored as a dry, protected ingredient because its functional performance is sensitive to moisture, heat, humidity, contamination, and prolonged adverse exposure. Although exact limits should follow the manufacturer's certificate, packaging instructions, and applicable pharmacopeial guidance, storage practice generally emphasizes cool, dry, clean, and well-ventilated conditions, with protection from direct sunlight, moisture sources, and odorous or hazardous materials.
Moisture control is central. Gelatin is hygroscopic and can absorb water from humid air, increasing moisture content and water activity at the particle surface. Moisture gain may cause clumping or caking, create conditions favorable to microbial growth during extended holding, and alter dissolution and handling. Conversely, improperly dried or over-dried material can lead to brittleness in finished shells, although this is also influenced by plasticization and formulation design. Sealed packaging should remain intact until use, and opened containers should be resealed promptly.
Warehouse controls include stock rotation, segregation from chemicals or non-food/non-pharmaceutical materials, pest control, and clean pallet storage away from walls and wet floors. Temperature and humidity monitoring helps identify seasonal or localized excursions. Because gelatin can absorb odors, it should not be stored near strongly scented products, solvents, volatile chemicals, or materials that could transfer taint.
During handling, dust control helps reduce cross-contamination, inhalation exposure, and residue buildup on equipment. Scoops, containers, and transfer systems should be clean, dry, and dedicated or controlled under appropriate hygiene procedures. Rehydration should follow validated formulation procedures: dry gelatin may be dispersed into water under controlled agitation to prevent lump formation, then allowed to hydrate before warming to the target processing temperature. Solutions should not be held longer than necessary at temperatures that permit microbial growth or property change.
Warning signs include off-odor, abnormal color, visible mold, wet packaging, hard caking, insect activity, unusual viscosity, poor clarification, or unexpected gel weakness. These conditions call for quarantine and quality review rather than routine use. Proper storage helps preserve Bloom strength and viscosity by limiting moisture cycling, hydrolysis, oxidation, and microbial exposure before the material enters pharmaceutical processing.
The pharmaceutical-grade status of gelatin is defined through a combination of pharmacopeial monographs, applicable excipient regulations, GMP-based manufacturing controls, animal-source documentation, and batch testing. Major pharmacopeias include the United States Pharmacopeia, European Pharmacopoeia, and Japanese Pharmacopoeia, each of which contains gelatin-related monographs and general test methods. Regional requirements may differ, so manufacturers and dosage-form producers should apply the current edition relevant to the market of use.
| Category | Expected control framework | Pharmaceutical relevance |
|---|---|---|
| Pharmacopeial-grade gelatin | Applicable pharmacopeial monograph tests, batch release documentation, GMP-based manufacturing controls, animal-source traceability, and formulation-specific qualification | Intended for evaluation as a pharmaceutical excipient when the specific grade and batch meet user and market requirements |
| Food-grade gelatin | Food-industry safety and quality controls applicable to its intended food use | Not automatically equivalent to pharmaceutical grade because documentation, residue, microbial, or traceability expectations may differ |
| Industrial-grade gelatin | Controls designed for non-pharmaceutical technical applications | Outside the pharmaceutical excipient framework discussed here |
Pharmacopeial monographs generally address identity, composition or description, key functional characteristics, purity, chemical residues, and microbiological quality. Typical tests cover identification, gel strength or Bloom-related behavior, viscosity, pH, moisture, ash, sulfur dioxide, heavy metals, insoluble or extraneous matter, microbial limits, and specified organisms where required. The monograph provides a compliance framework, but it does not replace formulation-specific qualification or finished-drug manufacturer responsibilities.
Because gelatin is animal-derived, BSE/TSE compliance concepts are a major regulatory focus. Documentation should support animal species, tissue type, geographic origin where relevant, supplier control, traceability, and handling of specified risk materials according to applicable requirements. Batch records should link incoming bovine hide or bone materials through processing to finished lots, enabling investigation and recall support if needed.
GMP documentation for pharma grade gelatin commonly includes approved supplier programs, raw material receiving records, processing parameters, purification and thermal-treatment records, laboratory results, deviation and change control, cleaning and hygiene records, packaging controls, and certificates of analysis. These records demonstrate that tested batches were produced under controlled conditions rather than selected only by final inspection.
The distinction between pharmacopeial, food, and industrial grades lies in the total control framework. Food gelatin may be suitable for food use but does not automatically meet pharmaceutical documentation, microbial, residue, or traceability expectations. Industrial gelatin is outside pharmaceutical excipient use. Compliance should be verified against current monographs and product-specific requirements; no grade designation alone substitutes for supplier qualification, incoming testing, and formulation-level validation.
Pharma grade gelatin is a collagen-derived bovine protein whose performance is determined by raw material source, conditioning route, controlled extraction, purification, and documented release testing. Hide and bone materials, together with Type A acid processing and Type B alkaline processing, create differences in molecular chain behavior and functional characteristics, while traceability and BSE/TSE-related source controls support animal-origin risk management.
Bloom strength and viscosity must be evaluated as separate but related parameters. Bloom reflects standardized gel firmness, whereas viscosity affects solution handling, capsule film formation, granulation, coating, and machine behavior. Molecular weight distribution, concentration, temperature, setting time, and ingredient interactions collectively determine the final gel network. Numeric targets should be confirmed against applicable COA data and formulation trials rather than treated as universal values.
In dosage forms, pharmaceutical gelatin supports hard capsule shells, plasticized softgel shells, tablet binding, film coatings, and microencapsulation, with compatibility assessed against water, glycerol, sorbitol, actives, and fill materials. Filtration, ion exchange, demineralization, thermal treatment, microbial testing, residue controls, and COA documentation reduce quality risks, although pharmacopeial-grade gelatin is not inherently sterile.
Dry, sealed storage, controlled humidity, hygienic handling, proper hydration, and stock rotation help preserve Bloom, viscosity, and microbial stability. Ultimately, pharmaceutical suitability depends on alignment with current USP, EP, or JP expectations as applicable, GMP records, batch traceability, and application-specific formulation qualification—not on grade labeling or any single specification.
At BEYOND BIOPHARMA, we view ourselves as an extension of your R&D team. We provide comprehensive technical documentation, stability data, and tailored samples to accelerate your product from concept to market leader-backed by our proven expertise.
Are you ready to experience the difference that 20 years of precision makes?
